NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









DAMAE Medical

DAMAE Medical

Private
ParisHealthcare & Life Scienceshttps://www.damae-medical.com/

Last Round

Series B

Nov 26, 2025

Total Funding Raised

$28.08M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

DAMAE Medical is a diagnostic equipment company that develops non-invasive, in-vivo imaging technology for the cellular-resolution diagnosis of skin cancers.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Revenue Share

AI Layer

Application

Keywords

optical biopsyfull-field optical coherence tomographyFF-OCTskin cancer detectionmedical imaging devicedermatology imagingnon-invasive diagnosticsdigital pathologyAI diagnostic assistmedical hardware3D image analysisvirtual biopsyskin imagingmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DAMAE Medical Comps

Public and private peers based on sector, stage, and business model.

DAMAE Medical comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

DAMAE Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BNov 26, 2025
Series AFeb 1, 2022
GrantSep 1, 2019
SeedApr 19, 2017

Key People

Founding team and executive leadership

Arnaud Dubois

Chief Scientific Officer Co-Founder

Founding Team

David SIRET

Co-founder CTO

Founding Team

Anaïs Barut

CEO And Co-founder

Founding Team

DAMAE Medical Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 13, 2026

    Open roles increased to 12, 6x the trailing average.

  • Nov 26, 2025

    $17.37M round completed.

DAMAE Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

DAMAE Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about DAMAE Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersParis
Employee Range49
Year Founded2014
Last FundingNov 26, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.